Bank of America’s Mirum Pharmaceuticals MIRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$19.8M Buy
389,270
+10,648
+3% +$542K ﹤0.01% 2226
2025
Q1
$17.1M Sell
378,622
-64,005
-14% -$2.88M ﹤0.01% 2257
2024
Q4
$18.3M Sell
442,627
-23,582
-5% -$975K ﹤0.01% 2041
2024
Q3
$18.2M Buy
466,209
+134,108
+40% +$5.23M ﹤0.01% 2142
2024
Q2
$11.4M Buy
332,101
+19,488
+6% +$666K ﹤0.01% 2451
2024
Q1
$7.85M Buy
312,613
+161,789
+107% +$4.06M ﹤0.01% 2735
2023
Q4
$4.45M Buy
150,824
+28,175
+23% +$832K ﹤0.01% 3017
2023
Q3
$3.88M Buy
122,649
+37,914
+45% +$1.2M ﹤0.01% 3026
2023
Q2
$2.19M Sell
84,735
-21,128
-20% -$547K ﹤0.01% 3491
2023
Q1
$2.54M Sell
105,863
-81,518
-44% -$1.96M ﹤0.01% 3527
2022
Q4
$3.65M Buy
187,381
+133,139
+245% +$2.6M ﹤0.01% 3171
2022
Q3
$1.14M Buy
54,242
+44,626
+464% +$937K ﹤0.01% 4097
2022
Q2
$187K Buy
9,616
+4,002
+71% +$77.8K ﹤0.01% 5385
2022
Q1
$124K Sell
5,614
-1,092
-16% -$24.1K ﹤0.01% 5972
2021
Q4
$107K Buy
6,706
+3,391
+102% +$54.1K ﹤0.01% 6021
2021
Q3
$66K Buy
3,315
+596
+22% +$11.9K ﹤0.01% 6035
2021
Q2
$47K Sell
2,719
-4,152
-60% -$71.8K ﹤0.01% 6055
2021
Q1
$136K Buy
6,871
+3,944
+135% +$78.1K ﹤0.01% 5597
2020
Q4
$52K Buy
2,927
+1,131
+63% +$20.1K ﹤0.01% 5556
2020
Q3
$35K Sell
1,796
-989
-36% -$19.3K ﹤0.01% 5490
2020
Q2
$55K Sell
2,785
-1,244
-31% -$24.6K ﹤0.01% 5364
2020
Q1
$57K Sell
4,029
-1,356
-25% -$19.2K ﹤0.01% 5225
2019
Q4
$132K Buy
5,385
+284
+6% +$6.96K ﹤0.01% 5059
2019
Q3
$51K Buy
+5,101
New +$51K ﹤0.01% 5489